SAC Capital Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3,900	Closed	-$44K	–	1810
2013 Q3	$44K	Sell	3,900 -696,100	-99%	-$7.85M	﹤0.01%	1649
2013 Q2	$9.37M	Buy	+700,000	New	+$9.37M	0.05%	348